CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
34.93
11-2月-25 16:45:00
15 分の遅延
株式
-1.60
-4.38%
本日の幅
34.42 - 36.66
ISIN
N/A
ソース
NASDAQ
-
10 2 2025 16:44:27 提供 Nasdaq GlobeNewswire
-
06 2 2025 16:35:20 提供 Nasdaq GlobeNewswire
-
10 1 2025 17:15:15 提供 Nasdaq GlobeNewswire
-
10 1 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
06 1 2025 08:00:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer
16 12 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
10 12 2024 20:44:38 提供 Nasdaq GlobeNewswire
-
09 12 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
15 11 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
12 11 2024 16:07:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
12 11 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
11 11 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024
16 10 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
10 10 2024 16:40:28 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
08 10 2024 23:55:11 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
08 10 2024 16:01:51 提供 Nasdaq GlobeNewswire
-
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
26 9 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
10 9 2024 16:40:25 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >